Alexandros Nianias

Research output

Research output per year 2019 2019 2020 2021 2022 2022

• 3 Meeting Abstract
• 1 Article
• 1 Review article

Research output per year

Research output per year

Search results

• 2022

  COMPARISON OF PROTOCOLS FOR CLINICALLY COMPATIBLE MANUFACTURING OF T CELLS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (HIPSC)

  Netsrithong, R., Nianias, A., Wang, J., Groen, R. & Themeli, M., 2022, In: Experimental Hematology. 111, p. S117-S117

  Research output: Contribution to journal › Meeting Abstract › Academic

• GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS

  Nianias, A., Katsarou, A., Prins, H-J., Shahrabi, A., van Velzen, C., Groen, R., Mutis, T. & Themeli, M., 2022, In: Experimental Hematology. 111, p. S118-S118

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2021

  Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence

  Katsarou, A., Sjöstrand, M., Naik, J., Mansilla-Soto, J., Kefala, D., Kladis, G., Nianias, A., Ruiter, R., Poels, R., Sarkar, I., Patankar, Y. R., Merino, E., Reijmers, R. M., Frerichs, K. A., Yuan, H., de Bruijn, J., Stroopinsky, D., Avigan, D., van de Donk, N. W. C. J., Zweegman, S., & 4 othersMutis, T., Sadelain, M., Groen, R. W. J. & Themeli, M., 8 Dec 2021, In: Science Translational Medicine. 13, 623, p. eabh1962

  Research output: Contribution to journal › Article › Academic › peer-review
  45 Citations (Scopus)
• 2020

  Co-Targeting CD38 with a Chimeric Costimulatory Receptor Enhances Adoptive T Cell Therapy for Hematological Malignancies

  Katsarou, A., Sjostrand, M. L., Nianias, A., Poels, R., Zweegman, S., Mutis, T., Sadelain, M., Groen, R. W. J. & Themeli, M., 28 Apr 2020, In: Molecular therapy. 28, 4, p. 40-41

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2019

  Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges

  Nianias, A. & Themeli, M., 15 Aug 2019, In: Current Hematologic Malignancy Reports. 14, 4, p. 261-268

  Research output: Contribution to journal › Review article › Academic › peer-review

  Open Access
  62 Citations (Scopus)